SCHEMBL536774

SCHEMBL536774

Cc1ccc(S(=O)(=O)Oc2nc(N)nc(-c3occc3C)c2[N+](=O)[O-])cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.38
NFE2L2 Q16236 1/20 0.38
CA12 O43570 1/20 0.36
CA2 P00918 1/20 0.36
CYP2C19 P33261 1/20 0.35
LMNA P02545 4/20 0.34
MAPT P10636 4/20 0.34
ADORA2A P29274 2/20 0.33
ADORA1 P30542 2/20 0.33
P2RY12 Q9H244 1/20 0.33
CYP1A2 P05177 1/20 0.32
HSP90AA1 P07900 2/20 0.32
NPY1R P25929 1/20 0.32
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 2/20 0.32
PKM P14618 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
MGMT P16455 3/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4051900 0.83 ADORA2A (0.48) KEAP1NFE2L2ADORA2AADORA1ALDH1A1
SCHEMBL3128908 0.75 CYP2C19 (0.47) KEAP1NFE2L2CA12CA2CYP2C19
SCHEMBL7484135 0.73 KEAP1 (0.51) KEAP1NFE2L2CYP2C19LMNAMAPT
SCHEMBL17585445 0.73 MAPT (0.46) KEAP1NFE2L2CYP2C19LMNAMAPT
SCHEMBL4322696 0.68 KEAP1 (0.53) KEAP1NFE2L2CYP2C19LMNAMAPT
SCHEMBL2492570 0.65 LMNA (0.44) KEAP1NFE2L2CA12CA2LMNA
SCHEMBL4129860 0.65 CYP2C19 (0.61) KEAP1NFE2L2CYP2C19P2RY12HSP90AA1
SCHEMBL4877590 0.64 CYP2C19 (0.51) KEAP1NFE2L2CA12CA2CYP2C19
SCHEMBL7151666 0.64 ADORA2A (0.51) ADORA2AADORA1
SCHEMBL7410681 0.64 KEAP1 (0.41) KEAP1NFE2L2CYP2C19LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2321321-B1 TRIAZOLO [4, 5-D]PYRAMIDINE DERIVATIVES AND THEIR USE AS PURINE RECEPTOR ANTAGONISTS VERNALIS R&D LTD (GB) 2012-02-08 EP disclosed